Blood-Based Metabolic Signature Outperforms Standard Method for Predicting Diet, Disease Risk
The method uses molecular profiling and AI to develop dietary signatures to predict cardiovascular disease and type 2 diabetes risks.
The method uses molecular profiling and AI to develop dietary signatures to predict cardiovascular disease and type 2 diabetes risks.
Researchers at NuraLogix developed AI models that can predict a person's risk of HbA1C levels and fasting blood glucose levels.
A new test could more accurately predict if individuals who undergo gastric bypass surgery will experience a remission of type 2 diabetes.
A new study aimed at reducing racial and ethnic disparities in diabetes diagnosis was recently conducted by a team of physician-scientists.
Read MoreEngineers have developed a prototype of such a wearable device that can continuously monitor glucose, alcohol, and lactate levels.
Read MoreA new study continues to validate the role that AGE biomarkers play in predicting if a person with diabetes will develop kidney disease.
Read MoreVersantis announced that Innosuisse will co-fund a project to develop a prototype portable POC device for blood ammonia monitoring.
Read MoreMore than half of people with diabetes will develop diabetic retinopathy, one of the leading causes of legal blindness in the U.S.
Read MoreAn international team of researchers has discovered the existence of three subtypes of...
Read MoreChildren who develop type 1 diabetes show epigenetic changes in the cells of their immune system before disease antibodies are detected.
Read MoreCOVID-19’s lockdowns in the UK left over a million people with diabetes without access to the routine HbA1C blood testing needed to manage their diabetes.
Read MoreMeasurement of dozens of types of fats in the blood can predict the risk of developing type 2 diabetes and cardiovascular disease years before their onset.
Read MoreThe ELF Test is a blood test that assesses prognosis in patients with advanced fibrosis due to non-alcoholic steatohepatitis (NASH).
Read MoreThe FDA Program will provide Life Science Biosensor Diagnostics with a path toward regulatory approval for its non-invasive, real-time saliva glucose test.
Read MoreSiemens Healthineer’s ELF Test performed the best of the five blood biomarkers selected for the FNIH NIMBLE Study.
Read MoreA needle-free technology that would allow people with diabetes to measure blood sugar levels has been bought closer to reality by researchers.
Read MoreThe FDA-cleared, POGO automatic blood glucose monitor features a 10-test cartridge for simplified testing.
Read MoreThe cordless DigiVibe device from BING Innovations uses vibration technology to ease the pain involved in finger-sticks for blood glucose monitoring.
Read More